Patent · US Expired

DSP-9 dual-specificity phosphatase

US6492157B1 · kind B1 · utility

0Cited by
2References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 6, 2000
Grant dateDec 10, 2002
Priority date
Expiry dateApr 6, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y301/03048
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods are provided for the treatment of conditions associated with cells proliferation, cells differentiation and cell survival. In particular, the dual-specificity phosphatase DSP-9, and polypeptide variants thereof that stimulate dephosphorylation of DSP-9 substrates, are provided. The polypeptides may be used, for example, to identify antibodies and other agents that inhibit DSP-9 activity. The polypeptides and agents may be used to modulate cell proliferation, differentiation and survival.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.